Harmony Biosciences Holdings, Inc. (HRMY)
28.52
-0.38
(-1.31%)
USD |
NASDAQ |
Mar 03, 14:57
Harmony Biosciences Holdings Total Liabilities (Quarterly) : 401.41M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Castle Biosciences, Inc. | 138.34M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Amicus Therapeutics, Inc. | 675.63M |
| Iovance Biotherapeutics, Inc. | 214.59M |
| Apellis Pharmaceuticals, Inc. | 705.11M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.272B |
| Shareholders Equity (Quarterly) | 870.22M |
| Debt to Equity Ratio | 0.2701 |
| Current Ratio | 3.597 |
| Net Debt Paydown Yield | -0.09% |